@article{article, title  = {{The pharmacological profile of a novel highly potent bisphosphonate, OX14 (1-fluoro-2-(imidazo-[1,2 alpha]pyridin-3-yl)ethyl-bisphosphonate), with reduced bone affinity, which is as effective as zoledronate in the treatment of myeloma bone disease in JJN3-NOD/SCID-[gamma] mice}},

 url = {{}},

 year = {{2016}},

 month = {{4}},

 author = {{Lawson M and Chantry A and Paton-Hough J and Evans H and Lath D and Tsoumpra M and Lundy M and Dobson R and Quijano M and Kwaasi A and Dunford J et al}},

 doi = {{10.1530/boneabs.5.p128}},

 journal = {{Bone Abstracts}},

 note = {{Accessed on 2024/12/22}}}